Jingyi Xie
Affiliations: | 2018- | Molecular Engineering | University of Washington, Seattle, Seattle, WA |
Google:
"Jingyi Xie"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chen DG, Xie J, Choi J, et al. (2024) Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer. Cell Reports. 43: 113872 |
| Chen DG, Xie J, Su Y, et al. (2024) T cell receptor sequences are the dominant factor contributing to the phenotype of CD8 T cells with specificities against immunogenic viral antigens. Cell Reports. 43: 113841 |
| Heath J, Chen D, Xie J, et al. (2023) An NKG2A biased immune response confers protection for infection, autoimmune disease, and cancer. Research Square |
| Chen DG, Xie J, Su Y, et al. (2023) T cell receptor sequences are the dominant factor contributing to the phenotype of CD8 T cells with specificities against immunogenic viral antigens. Cell Reports. 113279 |
| Chour W, Choi J, Xie J, et al. (2023) Large libraries of single-chain trimer peptide-MHCs enable antigen-specific CD8+ T cell discovery and analysis. Communications Biology. 6: 528 |
| Heath J, Chour W, Choi J, et al. (2022) Large libraries of single-chain trimer peptide-MHCs enable rapid antigen-specific CD8+ T cell discovery and analysis. Research Square |
| Su Y, Yuan D, Chen DG, et al. (2022) Multiple early factors anticipate post-acute COVID-19 sequelae. Cell |
| Nesterenko PA, McLaughlin J, Tsai BL, et al. (2021) HLA-A02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses. Cell Reports. 110167 |
| Lee JW, Su Y, Baloni P, et al. (2021) Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19. Nature Biotechnology |
| Su Y, Chen D, Yuan D, et al. (2020) Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19. Cell |